ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,066.44
0.67%
US Tech 100
21,136.00
1.05%
다우존스 지수
44,470.41
0.38%
Bitcoin
98,322.44
0.86%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Keros Therapeutics Inc (KROS)

  7. Keros Therapeutics Inc (KROS) 뉴스

KROS

Keros Therapeutics (KROS)

Keros Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:KROS
일자시간출처헤드라인심볼기업
2025/01/3022:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2025/01/3022:00GlobeNewswire Inc.Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech ConferenceNASDAQ:KROSKeros Therapeutics Inc
2025/01/2506:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:KROSKeros Therapeutics Inc
2025/01/2122:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2025/01/2122:00GlobeNewswire Inc.Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance ElriterceptNASDAQ:KROSKeros Therapeutics Inc
2025/01/1520:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2025/01/1520:30GlobeNewswire Inc.Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS TrialNASDAQ:KROSKeros Therapeutics Inc
2025/01/1022:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/12/1220:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/12/1220:00GlobeNewswire Inc.Keros Therapeutics Announces Update on the Phase 2 TROPOS TrialNASDAQ:KROSKeros Therapeutics Inc
2024/12/1009:30GlobeNewswire Inc.Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and ExpositionNASDAQ:KROSKeros Therapeutics Inc
2024/12/0321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/12/0321:00GlobeNewswire Inc.Keros Therapeutics Announces Global License Agreement with Takeda to Advance ElriterceptNASDAQ:KROSKeros Therapeutics Inc
2024/11/2622:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/11/2622:00GlobeNewswire Inc.Keros Therapeutics Announces Participation at Upcoming Healthcare ConferencesNASDAQ:KROSKeros Therapeutics Inc
2024/11/1306:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
2024/11/0906:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
2024/11/0706:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KROSKeros Therapeutics Inc
2024/11/0706:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/11/0622:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/11/0622:00GlobeNewswire Inc.Keros Therapeutics to Present at the Guggenheim Healthcare Innovation ConferenceNASDAQ:KROSKeros Therapeutics Inc
2024/11/0523:00GlobeNewswire Inc.Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and ExpositionNASDAQ:KROSKeros Therapeutics Inc
2024/10/1621:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/10/1621:00GlobeNewswire Inc.Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical OfficerNASDAQ:KROSKeros Therapeutics Inc
2024/09/3021:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/09/1221:00GlobeNewswire Inc.Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare ConferenceNASDAQ:KROSKeros Therapeutics Inc
2024/09/0321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/09/0321:00GlobeNewswire Inc.Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS TrialNASDAQ:KROSKeros Therapeutics Inc
2024/08/2821:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
2024/08/2821:00GlobeNewswire Inc.Keros Therapeutics Announces Participation at Upcoming Healthcare ConferencesNASDAQ:KROSKeros Therapeutics Inc
 검색 관련기사 보기:NASDAQ:KROS

최근 히스토리

CCOM
US100
US Tech 100
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
CCOM
US500
US 500
NYSE
DIS
Walt Disney
COIN
ADAUSD
Cardano
NYSE
AXP
American Express
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
COIN
DOGEUSD
Dogecoin
NYSE
MRK
Merck
FX
USDJPY
US Dollar vs Yen
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지